Register Now! Join our very own Michael Koratich as he dives into preclinical and regulatory strategies to advance ADC therapies into the clinic.
🔍 💡 Join Translational Drug Development (TD2) for an upcoming webinar exploring the development of antibody-drug conjugates, a groundbreaking advancement in targeted cancer therapies. Michael Koratich will dive into preclinical strategies for optimizing antibody-drug conjugates, including key in vitro and in vivo evaluation methods, and gain insights into navigating the regulatory landscape. 🔬 The session will also feature case studies of successful therapies, highlighting critical factors for regulatory approval and clinical success. ➡️ REGISTER HERE: https://buff.ly/4882zb8 #DrugDevelopment #PrecisionMedicine #ClinicalResearch #Oncology #InVitro #InVivo #TherapeuticAreas #AntibodyDrugConjugate #OncologyDrugDevelopment #CellAndGeneTherapies